50258
POPULAR PHARMACEUTICALS LTD
Jan 6, 2026
Bangladesh
South Asia
Feb 5, 2026
B - Limited
Pending Approval
Jan 6, 2026
Regional Industry - MAS Asia & Pac
other
Pharmaceuticals and Medicine Manufacturing
The proposed investment is for up to US$30.7 million (“IFC Loan”) to Popular Pharmaceuticals PLC. (“PPL” or the “Company” or the “Borrower”) in Bangladesh.
Founded in 2006, PPL is a well-established, mid-sized pharmaceutical manufacturer in Bangladesh. The Company ranks 9th by revenue in Bangladesh pharma market. PPL belongs to Popular Group, which is a leading, family-owned healthcare conglomerate in Bangladesh with a 41-year track record across diagnostics, pharmaceuticals, hospitals, and medical education
The IFC Loan proceeds will be used to finance working capital, primarily for the procurement of raw materials, which are mostly imported. The transaction aims to ensure uninterrupted supply of essential medicines during a period of financial sector stress and credit tightening in Bangladesh. A long-term US$-denominated loan will enable the Company to navigate the current financial sector stress and credit tightness and maintain continuity of operations.
IFC will support PPL to improve gender diversity and inclusion in their workplace by providing recommendations, guidance, and tools to improve policies and practices to support workplace participation of all genders, particularly women through gender advisory.
For Inquiries About the Project, Contact
For Inquiries and Comments About IFC, Contact
Local Access of Project Documentation
Mr. Safiul Azam, Director, Finance and Accounts, Popular Pharmaceuticals PLC., 17 Shukrabad, West Panthapath, Mohammadpur Housing, Dhaka, 1207, Bangladesh